Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Rifabutin | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Rifabutin | hsa00512 | Mucin type O-glycan biosynthesis | 4.86E-02 | 2 | O95395, Q9NY28 | GCNT3, GALNT8 | More | | Rifabutin | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Rifabutin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.56E-05 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Rifabutin | hsa00920 | Sulfur metabolism | 8.89E-03 | 1 | Q16762 | TST | More | | Rifabutin | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.10E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Rifabutin | hsa00982 | Drug metabolism - cytochrome P450 | 3.10E-02 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Rifabutin | hsa03010 | Ribosome | 4.08E-06 | 13 | P62753, P25398, P32969, P62906, P62829, P46776, Q07020, P18077, P61513, P36578, P27635, P62249, P23396 | RPS6, RPS12, RPL9, RPL10A, RPL23, RPL27A, RPL18, RPL35A, RPL37A, RPL4, RPL10, RPS16, RPS3 | More | | Rifabutin | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Rifabutin | hsa03040 | Spliceosome | 9.25E-07 | 13 | Q14562, O43143, O60508, P17844, P08579, P51991, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142 | DHX8, DHX15, CDC40, DDX5, SNRPB2, HNRPA3, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8 | More | | Rifabutin | hsa04014 | Ras signaling pathway | 1.07E-03 | 10 | P20827, Q9NRA1, P49767, Q13009, Q14644, P0DP23, P62873, P63218, P50151, P19174 | EFNA1, PDGFC, VEGFC, TIAM1, RASA3, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Rifabutin | hsa04020 | Calcium signaling pathway | 3.36E-03 | 6 | Q16566, P30679, O15399, P0DP23, P23634, P49767 | CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Rifabutin | hsa04062 | Chemokine signaling pathway | 1.59E-03 | 9 | P07948, P19174, P62873, P63218, P50151, Q13009, P14598, P42224, P25963 | LYN, PLCG1, GNB1, GNG5, GNG10, TIAM1, NCF1, STAT1, NFKBIA | More | | Rifabutin | hsa04070 | Phosphatidylinositol signaling system | 2.93E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Rifabutin | hsa04122 | Sulfur relay system | 8.89E-03 | 1 | Q16762 | TST | More | | Rifabutin | hsa04141 | Protein processing in endoplasmic reticulum | 5.21E-08 | 14 | P18848, P30101, Q15437, Q15436, O60337, P60604, Q99941, P11142, P07900, P08238, Q9NR31, P14625, Q9H173, Q9UNL2 | ATF4, PDIA3, SEC23B, SEC23A, MARH6, UBE2G2, CREBL1, HSPA8, HSP90AA1, HSP90AB1, SAR1A, HSP90B1, SIL1, SSR3 | More | | Rifabutin | hsa04145 | Phagosome | 6.51E-03 | 6 | P11215, P14598, Q71U36, Q13509, P68371, Q13488 | ITGAM, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1 | More | | Rifabutin | hsa04151 | PI3K-Akt signaling pathway | 5.74E-06 | 9 | P62753, P27348, P07900, P14625, Q16363, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, HSP90B1, LAMA4, TNXB, CREBL1, ATF4, SGK | More | | Rifabutin | hsa04211 | Longevity regulating pathway | 1.79E-03 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Rifabutin | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Rifabutin | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | | Rifabutin | hsa04261 | Adrenergic signaling in cardiomyocytes | 5.74E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Rifabutin | hsa04371 | Apelin signaling pathway | 1.23E-04 | 9 | P62873, P63218, P50151, Q13370, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Rifabutin | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Rifabutin | hsa04540 | Gap junction | 1.08E-02 | 4 | Q13509, P68371, Q71U36, Q9NRA1 | TUBB3, TUBB2C, TUBA1A, PDGFC | More | | Rifabutin | hsa04610 | Complement and coagulation cascades | 4.48E-02 | 3 | P01042, P09871, P11215 | KNG1, C1S, ITGAM | More | | Rifabutin | hsa04614 | Renin-angiotensin system | 3.52E-02 | 1 | P10619 | CTSA | More | | Rifabutin | hsa04623 | Cytosolic DNA-sensing pathway | 2.59E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Rifabutin | hsa04657 | IL-17 signaling pathway | 4.87E-02 | 2 | P07900, P01584 | HSP90AA1, IL1B | More | | Rifabutin | hsa04659 | Th17 cell differentiation | 1.12E-03 | 7 | P25963, P19174, P42224, P14784, P84022, Q13485, P08238 | NFKBIA, PLCG1, STAT1, IL2RB, SMAD3, SMAD4, HSP90AB1 | More | | Rifabutin | hsa04664 | Fc epsilon RI signaling pathway | 6.97E-03 | 4 | P04141, P07948, P19174, P09917 | CSF2, LYN, PLCG1, ALOX5 | More | | Rifabutin | hsa04713 | Circadian entrainment | 2.18E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Rifabutin | hsa04714 | Thermogenesis | 2.88E-03 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Rifabutin | hsa04720 | Long-term potentiation | 1.79E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Rifabutin | hsa04724 | Glutamatergic synapse | 1.74E-03 | 6 | O15399, P62873, P63218, P50151, P15104, Q9NSB8 | GRIN2D, GNB1, GNG5, GNG10, GLUL, HOMER2 | More | | Rifabutin | hsa04725 | Cholinergic synapse | 1.14E-03 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Rifabutin | hsa04726 | Serotonergic synapse | 3.80E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Rifabutin | hsa04727 | GABAergic synapse | 4.18E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Rifabutin | hsa04728 | Dopaminergic synapse | 5.46E-03 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Rifabutin | hsa04730 | Long-term depression | 4.86E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Rifabutin | hsa04744 | Phototransduction | 9.21E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Rifabutin | hsa04911 | Insulin secretion | 3.90E-07 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Rifabutin | hsa04912 | GnRH signaling pathway | 1.14E-03 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Rifabutin | hsa04915 | Estrogen signaling pathway | 2.21E-05 | 5 | Q99941, P18848, P51828, P07900, P11142 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8 | More | | Rifabutin | hsa04918 | Thyroid hormone synthesis | 1.01E-06 | 5 | P51828, Q99941, P18848, P14625, P02768 | ADCY7, CREBL1, ATF4, HSP90B1, ALB | More | | Rifabutin | hsa04924 | Renin secretion | 4.38E-02 | 1 | P07550 | ADRB2 | More | | Rifabutin | hsa04925 | Aldosterone synthesis and secretion | 1.39E-06 | 7 | Q99941, P18848, P51828, P0DP23, Q16566, Q13557, P23634 | CREBL1, ATF4, ADCY7, CALM1, CAMK4, CAMK2D, ATP2B4 | More | | Rifabutin | hsa04926 | Relaxin signaling pathway | 2.69E-03 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Rifabutin | hsa04927 | Cortisol synthesis and secretion | 3.89E-05 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Rifabutin | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.14E-03 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Rifabutin | hsa04932 | Non-alcoholic fatty liver disease | 9.70E-03 | 4 | P18848, P01584, P13073, O15239 | ATF4, IL1B, COX4I1, NDUFA1 | More | | Rifabutin | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rifabutin | hsa04934 | Cushing syndrome | 3.21E-06 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Rifabutin | hsa04935 | Growth hormone synthesis, secretion and action | 1.79E-03 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Rifabutin | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Rifabutin | hsa05012 | Parkinson disease | 2.58E-03 | 11 | O15239, P13073, P05141, P60604, P18848, P19174, P0DP23, Q13557, Q71U36, Q13509, P68371 | NDUFA1, COX4I1, SLC25A5, UBE2G2, ATF4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3, TUBB2C | More | | Rifabutin | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Rifabutin | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Rifabutin | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | | Rifabutin | hsa05030 | Cocaine addiction | 4.88E-03 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Rifabutin | hsa05031 | Amphetamine addiction | 9.52E-05 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Rifabutin | hsa05032 | Morphine addiction | 2.18E-02 | 4 | P62873, P63218, P50151, Q13370 | GNB1, GNG5, GNG10, PDE3B | More | | Rifabutin | hsa05034 | Alcoholism | 1.05E-02 | 6 | O15399, Q16566, P0DP23, P63218, O60814, P68431 | GRIN2D, CAMK4, CALM1, GNG5, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Rifabutin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.08E-02 | 4 | P25963, Q13488, P19174, P07948 | NFKBIA, TCIRG1, PLCG1, LYN | More | | Rifabutin | hsa05130 | Pathogenic Escherichia coli infection | 3.19E-02 | 6 | Q71U36, P16333, Q13509, P68371, Q14344, P25963 | TUBA1A, NCK1, TUBB3, TUBB2C, GNA13, NFKBIA | More | | Rifabutin | hsa05132 | Salmonella infection | 2.19E-03 | 10 | P25963, P08238, Q13489, P10415, O75369, Q9BQS8, Q71U36, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, BIRC3, BCL2, FLNB, FYCO1, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Rifabutin | hsa05133 | Pertussis | 1.70E-03 | 4 | P11215, P0DP23, P23528, P09871 | ITGAM, CALM1, CFL1, C1S | More | | Rifabutin | hsa05134 | Legionellosis | 2.12E-03 | 5 | P01584, P25963, P11215, P68104, P11142 | IL1B, NFKBIA, ITGAM, EEF1A1, HSPA8 | More | | Rifabutin | hsa05140 | Leishmaniasis | 4.82E-02 | 4 | P14598, P11215, P42224, P25963 | NCF1, ITGAM, STAT1, NFKBIA | More | | Rifabutin | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Rifabutin | hsa05161 | Hepatitis B | 1.01E-04 | 7 | Q99941, P18848, P25963, Q13485, P10415, P27348, P84022 | CREBL1, ATF4, NFKBIA, SMAD4, BCL2, YWHAQ, SMAD3 | More | | Rifabutin | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Rifabutin | hsa05163 | Human cytomegalovirus infection | 2.56E-03 | 8 | P25963, P62873, P63218, P50151, P0DP23, Q14344, P30101, P01568 | NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, PDIA3, IFNA21 | More | | Rifabutin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 8.62E-05 | 10 | P01568, P42224, P25963, P62873, P63218, P50151, P19174, P07948, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, GNB1, GNG5, GNG10, PLCG1, LYN, CSF2, CALM1 | More | | Rifabutin | hsa05168 | Herpes simplex virus 1 infection | 3.79E-02 | 9 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, ZNF211, ZNF189 | More | | Rifabutin | hsa05170 | Human immunodeficiency virus 1 infection | 1.19E-02 | 8 | P62873, P63218, P50151, P0DP23, P30101, P01568, P25963, P19174 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, NFKBIA, PLCG1 | More | | Rifabutin | hsa05171 | Coronavirus disease - COVID-19 | 3.99E-06 | 14 | P01584, P23396, P62753, P25398, P62249, P62906, P36578, P32969, P27635, Q07020, P46776, P18077, P61513, P62829 | IL1B, RPS3, RPS6, RPS12, RPS16, RPL10A, RPL4, RPL9, RPL10, RPL18, RPL27A, RPL35A, RPL37A, RPL23 | More | | Rifabutin | hsa05200 | Pathways in cancer | 1.99E-03 | 15 | P08238, P42224, P25963, P19174, P43246, P84022, P20585, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, MSH3, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Rifabutin | hsa05203 | Viral carcinogenesis | 5.74E-04 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | | Rifabutin | hsa05204 | Chemical carcinogenesis | 4.92E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Rifabutin | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rifabutin | hsa05212 | Pancreatic cancer | 4.70E-03 | 4 | P42224, P84022, Q13485, O75293 | STAT1, SMAD3, SMAD4, GADD45B | More | | Rifabutin | hsa05214 | Glioma | 4.75E-02 | 3 | P0DP23, P19174, O75293 | CALM1, PLCG1, GADD45B | More | | Rifabutin | hsa05215 | Prostate cancer | 4.48E-02 | 2 | P18848, P14625 | ATF4, HSP90B1 | More | | Rifabutin | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Rifabutin | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Rifabutin | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rifabutin | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | |